These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2453699)

  • 1. [Use of combinations of group I anti-arrhythmia drugs in patients with refractory arrhythmias].
    Abdalla A; Mazur NA; Ivanova LA; Sumarokov AV
    Kardiologiia; 1988 Feb; 28(2):42-6. PubMed ID: 2453699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experience in using anti-arrhythmia preparations of groups I and III in patients with arrhythmia resistant to therapy].
    Abdalla A; Mazur NA
    Kardiologiia; 1988 Mar; 28(3):51-4. PubMed ID: 2454343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of the effectiveness of ethacizine, etmozin and Ritmilen in patients with ventricular rhythmic disorders].
    Smetnev AS; Ponomarenko EL; Koltunova MI; Shugushev KhKh
    Kardiologiia; 1987 May; 27(5):24-6. PubMed ID: 2443743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombocyte aggregation in patients with cardiac arrhythmias and effect of anti-arrhythmia agents].
    Kurbanov RD; Azimova NA; Kiakbaev GK; Abdullaev TA; Asriiants LS; Zakirov NU; Avezov DK; Faĭzullaev BP
    Kardiologiia; 1993; 33(5):27-9. PubMed ID: 7526023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics and pharmacodynamics of the new Russian anti-arrhythmia drug allapinin].
    Abdalla A; Rulin VA; Mazur NA; Sumarokov AB; Chikovani SI
    Kardiologiia; 1989 Jan; 29(1):32-6. PubMed ID: 2471868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative effectiveness of ethmozine, mexitil, quinidine and obsidan in the treatment of ventricular rhythm disorders].
    Kurbanov RD; Mazur NA
    Kardiologiia; 1981 Oct; 21(10):59-64. PubMed ID: 6170776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of the antiarrhythmic action of Mexityl in ventricular disorders of the cardiac rhythm].
    Mazur NA; Liakishev AA; Podrid FD; Piotrovskiĭ VK
    Kardiologiia; 1979 Oct; 19(10):17-21. PubMed ID: 91699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Safety of long-term therapy with a combination of various anti-arrhythmia agents].
    Abdalla A; Mazur NA; Sumarokov AB; Iavorskaia NV
    Klin Med (Mosk); 1989 Mar; 67(3):79-82. PubMed ID: 2473246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative effectiveness of neogilurytmal, novocainamide, etmozin, disopyramide and ethacizine in ventricular arrhythmias].
    Shpektor AV; Gorshkov VA; Mamaev VI
    Klin Med (Mosk); 1987 Jan; 65(1):49-52. PubMed ID: 2435956
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effectiveness of a combination of mexitil with etmozin, allapinin or quinidine in ventricular extrasystole].
    Abdalla A; Mazur NA
    Klin Med (Mosk); 1988 May; 66(5):57-60. PubMed ID: 2458502
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combination treatment of atrial arrhythmias with quinidine-verapamil].
    Gülker H; Bramann HU; Brisse B; Kuhs H
    Med Klin; 1980 Feb; 75(5):196-8. PubMed ID: 6156393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination therapy with anti-arrhythmia agents].
    Kettner W; Götze C
    Z Arztl Fortbild (Jena); 1986; 80(21):889-92. PubMed ID: 2436386
    [No Abstract]   [Full Text] [Related]  

  • 13. [Differential indications for anti-arrhythmia therapy].
    Manz M; Wagner WL; Lüderitz B
    Internist (Berl); 1987 Mar; 28(3):182-9. PubMed ID: 2438248
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative effectiveness of class I anti-arrhythmia drugs and the algorithms of their selection in patients with ventricular arrhythmia].
    Abdalla A; Mazur NA; Nazarenko VA
    Kardiologiia; 1991 Jun; 31(6):22-5. PubMed ID: 1717733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calcium metabolism and transmembrane potential of thrombocytes in patients with frequent ventricular extrasystole treated with anti-arrhythmia drugs].
    Mazaev AV; Me'nshikov MIu; Bugriĭ EM; Avdonin LV; Ku'zmin AV
    Kardiologiia; 1989 Jan; 29(1):17-21. PubMed ID: 2471867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative evaluation of the anti-arrhythmia effect of the antioxidant ionol (dibunol) in the arrhythmic form of neurocirculatory asthenia and stable exertion-induced stenocardia].
    Meerson FZ; Korochkin IM; Barbarash OL
    Sov Med; 1990; (3):67-70. PubMed ID: 1695023
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical studies of Norpace (Part XI).
    Nisbet T
    Angiology; 1975 Jan; 26(1 Pt 2):149-53. PubMed ID: 46729
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-arrhythmia effect of prolecophen in patients with extrasystole in comparison with other anti-arrhythmia drugs].
    Abdalla A; Mazur NA; Sumarokov AB
    Kardiologiia; 1989 Oct; 29(10):97-9. PubMed ID: 2482381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prospective evolution of the efficacy of antiarrhythmia therapy in paroxysmal supraventricular tachycardia in patients with the ventricular pre-excitation syndrome].
    Fomina IG; Iankin VV
    Klin Med (Mosk); 1992 Jan; 70(1):26-32. PubMed ID: 1608203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intrauterine diagnosis and therapy of fetal arrhythmias].
    Gembruch U; Somville T
    Gynakologe; 1995 Oct; 28(5):329-45. PubMed ID: 7498829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.